Wyeth Japan Appoints New President
This article was originally published in PharmAsia News
Michael Goettler took over as Wyeth Japan president Sept. 17; he replaced Susumu Kurata, who will remain as an executive director until Sept. 30. At the age of 41, Goettler worked at Hoechst AG, Aventis Pharmaceutical before he became marketing division head for Sanofi Aventis in 2005. He later served as the vice president for Wyeth Pharmaceuticals' biopharma division, and in 2008 he assumed the role of marketing vice president in charge of opioid constipation drug Relistor (methylnaltrexone). (Click here for more - Japanese language
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.